Indiana University Health Arnett, Nephrology Department, HemoCleanse Technologies, LLC, Lafayette, Indiana, USA.
Artif Organs. 2022 May;46(5):972-976. doi: 10.1111/aor.14230. Epub 2022 Mar 21.
By the year 2000, there was rising interest in home hemodialysis in the United States. HemoCleanse decided to resurrect the BioLogic-HD machine, using updated components. A spin-off company Renal Solutions (RSI) created the Allient™, with sorbent regeneration of dialysate, hollow fiber dialyzer, pressure-controlled blood flow rate, controlled filtration, and single- or dual-needle access. RSI merged with Sorb Technology and the Allient™ was built, tested, and FDA-approved to market. In 2007 Fresenius Medical Corporation (FMC) bought RSI. FMC began an extensive re-design of the machine to fit the needs of both in-center and home dialysis. The redesigned machine never was marketed.
到 2000 年，美国对家庭血液透析的兴趣日益浓厚。HemoCleanse 决定使用更新的组件来复活 BioLogic-HD 机器。一家名为 Renal Solutions (RSI) 的衍生公司制造了 Allient™，它采用了透析液再生吸附剂、空心纤维透析器、压力控制血流速度、控制过滤以及单针或双针进入。RSI 与 Sorb Technology 合并，Allient™ 经过测试并获得 FDA 批准上市。2007 年，费森尤斯医疗公司 (FMC) 收购了 RSI。FMC 开始对机器进行广泛的重新设计，以满足中心和家庭透析的需求。重新设计的机器从未上市。
